SEC Form 4 · accession 0001683168-26-005423
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philippe Weigerstorfer
Director
Period of report
Jul 9, 2026
Accepted (ET)
Jul 9, 2026 · 8:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2,F1 | $1.26 | Jul 9, 2026 | A | 10,000 | A | — | Jul 9, 2036 | Common Stock | 10,000 | 30,001 | D |
Explanation of responses
- F1The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control.
- F2The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors.